U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885475) titled 'Dexmedetomidine for Refractory Pain in Palliative Cancer Patients' on June 15.
Brief Summary: The goal of this study is to find out whether the medication dexmedetomidine can be a safe and effective additional treatment for cancer patients whose pain is not well controlled by standard pain medicines (such as opioids).
The study includes 30 palliative care patients who still have significant pain despite standard pain treatment. All participants will receive dexmedetomidine, and outcomes related to efficacy and safety will be systematically observed.
Study Start Date: April 10
Study Type: OBSERVATIONAL
Condition:
Cancer
Palliati...